S&P 500   4,367.00 (+0.94%)
DOW   34,298.10 (+0.40%)
QQQ   347.52 (+1.88%)
AAPL   168.63 (+5.91%)
MSFT   304.01 (+1.39%)
FB   297.81 (+1.08%)
GOOGL   2,633.49 (+2.07%)
AMZN   2,830.25 (+1.34%)
TSLA   842.85 (+1.66%)
NVDA   223.30 (+1.76%)
BABA   112.73 (+0.84%)
NIO   20.76 (-1.66%)
AMD   103.70 (+1.07%)
CGC   7.20 (+5.11%)
MU   77.44 (-1.63%)
GE   90.88 (+1.09%)
T   24.83 (+2.94%)
F   19.33 (-1.13%)
DIS   136.36 (+0.69%)
AMC   14.91 (+2.69%)
PFE   54.44 (+2.00%)
ACB   3.86 (+1.85%)
BA   188.10 (-0.87%)
S&P 500   4,367.00 (+0.94%)
DOW   34,298.10 (+0.40%)
QQQ   347.52 (+1.88%)
AAPL   168.63 (+5.91%)
MSFT   304.01 (+1.39%)
FB   297.81 (+1.08%)
GOOGL   2,633.49 (+2.07%)
AMZN   2,830.25 (+1.34%)
TSLA   842.85 (+1.66%)
NVDA   223.30 (+1.76%)
BABA   112.73 (+0.84%)
NIO   20.76 (-1.66%)
AMD   103.70 (+1.07%)
CGC   7.20 (+5.11%)
MU   77.44 (-1.63%)
GE   90.88 (+1.09%)
T   24.83 (+2.94%)
F   19.33 (-1.13%)
DIS   136.36 (+0.69%)
AMC   14.91 (+2.69%)
PFE   54.44 (+2.00%)
ACB   3.86 (+1.85%)
BA   188.10 (-0.87%)
S&P 500   4,367.00 (+0.94%)
DOW   34,298.10 (+0.40%)
QQQ   347.52 (+1.88%)
AAPL   168.63 (+5.91%)
MSFT   304.01 (+1.39%)
FB   297.81 (+1.08%)
GOOGL   2,633.49 (+2.07%)
AMZN   2,830.25 (+1.34%)
TSLA   842.85 (+1.66%)
NVDA   223.30 (+1.76%)
BABA   112.73 (+0.84%)
NIO   20.76 (-1.66%)
AMD   103.70 (+1.07%)
CGC   7.20 (+5.11%)
MU   77.44 (-1.63%)
GE   90.88 (+1.09%)
T   24.83 (+2.94%)
F   19.33 (-1.13%)
DIS   136.36 (+0.69%)
AMC   14.91 (+2.69%)
PFE   54.44 (+2.00%)
ACB   3.86 (+1.85%)
BA   188.10 (-0.87%)
S&P 500   4,367.00 (+0.94%)
DOW   34,298.10 (+0.40%)
QQQ   347.52 (+1.88%)
AAPL   168.63 (+5.91%)
MSFT   304.01 (+1.39%)
FB   297.81 (+1.08%)
GOOGL   2,633.49 (+2.07%)
AMZN   2,830.25 (+1.34%)
TSLA   842.85 (+1.66%)
NVDA   223.30 (+1.76%)
BABA   112.73 (+0.84%)
NIO   20.76 (-1.66%)
AMD   103.70 (+1.07%)
CGC   7.20 (+5.11%)
MU   77.44 (-1.63%)
GE   90.88 (+1.09%)
T   24.83 (+2.94%)
F   19.33 (-1.13%)
DIS   136.36 (+0.69%)
AMC   14.91 (+2.69%)
PFE   54.44 (+2.00%)
ACB   3.86 (+1.85%)
BA   188.10 (-0.87%)
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA Stock Forecast, Price & News

$33.59
+0.05 (+0.15%)
(As of 01/28/2022 12:14 PM ET)
Add
Compare
Today's Range
$33.38
$33.64
50-Day Range
$29.82
$34.64
52-Week Range
$29.71
$42.45
Volume
4,609 shs
Average Volume
493,677 shs
Market Capitalization
$19.68 billion
P/E Ratio
17.96
Dividend Yield
1.71%
Beta
1.26
30 days | 90 days | 365 days | Advanced Chart
Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.


Fresenius Medical Care AG & Co. KGaA logo

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Headlines

Fresenius Medical Care(FMS)
September 16, 2021 |  fool.com
See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
125,364
Year Founded
1912

Sales & Book Value

Annual Sales
$20.40 billion
Cash Flow
$5.95 per share
Book Value
$24.05 per share

Profitability

Net Income
$1.33 billion
Pretax Margin
9.05%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$19.68 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/02/2021
Today
1/28/2022
Next Earnings (Estimated)
2/22/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.13 out of 5 stars

Medical Sector

486th out of 1,417 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

10th out of 21 stocks

Analyst Opinion: 3.1Community Rank: 3.6Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Frequently Asked Questions

Is Fresenius Medical Care AG & Co. KGaA a buy right now?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 1 sell rating, 12 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Fresenius Medical Care AG & Co. KGaA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View analyst ratings for Fresenius Medical Care AG & Co. KGaA
or view top-rated stocks.

How has Fresenius Medical Care AG & Co. KGaA's stock price been impacted by Coronavirus (COVID-19)?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $35.43 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, FMS stock has decreased by 5.2% and is now trading at $33.59.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 713,300 shares, an increase of 30.0% from the December 31st total of 548,900 shares. Based on an average trading volume of 406,300 shares, the short-interest ratio is currently 1.8 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

Fresenius Medical Care AG & Co. KGaA is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Fresenius Medical Care AG & Co. KGaA
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its quarterly earnings data on Tuesday, November, 2nd. The company reported $0.55 earnings per share for the quarter, hitting the Zacks' consensus estimate of $0.55. The business earned $5.24 billion during the quarter, compared to analysts' expectations of $5.37 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 5.28% and a trailing twelve-month return on equity of 8.74%.
View Fresenius Medical Care AG & Co. KGaA's earnings history
.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA announced an annual dividend on Monday, May 17th. Shareholders of record on Tuesday, May 25th will be paid a dividend of $0.8338 per share on Monday, June 7th. This represents a yield of 2.7%. The ex-dividend date is Monday, May 24th. This is a positive change from Fresenius Medical Care AG & Co. KGaA's previous annual dividend of $0.71.
View Fresenius Medical Care AG & Co. KGaA's dividend history
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.57 per share and currently has a dividend yield of 1.71%. Fresenius Medical Care AG & Co. KGaA has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 30.48%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 27.40% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius Medical Care AG & Co. KGaA's dividend history.

What price target have analysts set for FMS?

18 brokers have issued 12-month target prices for Fresenius Medical Care AG & Co. KGaA's shares. Their forecasts range from $35.00 to $40.00. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's share price to reach $37.50 in the next year. This suggests a possible upside of 11.6% from the stock's current price.
View analysts' price targets for Fresenius Medical Care AG & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are Fresenius Medical Care AG & Co. KGaA's key executives?

Fresenius Medical Care AG & Co. KGaA's management team includes the following people:
  • Rice Powell, Chief Executive Officer
  • Helen Giza, Chief Financial & Transformation Officer
  • Franklin W. Maddux, Global Chief Medical Officer
  • Olaf Schermeier, CEO-Global Research & Development
  • Dominik Heger, Senior VP, Head-IR & Corporate Communications

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's stock is owned by a variety of retail and institutional investors. Top institutional investors include Cambiar Investors LLC (0.20%), Capital Insight Partners LLC (0.01%), Crossmark Global Holdings Inc. (0.01%), Russell Investments Group Ltd. (0.01%), Janney Montgomery Scott LLC (0.01%) and Cacti Asset Management LLC (0.00%).

Which institutional investors are selling Fresenius Medical Care AG & Co. KGaA stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, and Parallel Advisors LLC.

Which institutional investors are buying Fresenius Medical Care AG & Co. KGaA stock?

FMS stock was purchased by a variety of institutional investors in the last quarter, including Capital Insight Partners LLC, Russell Investments Group Ltd., Cacti Asset Management LLC, Crossmark Global Holdings Inc., Janney Montgomery Scott LLC, First PREMIER Bank, and Ellevest Inc..

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $33.59.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA has a market capitalization of $19.68 billion and generates $20.40 billion in revenue each year. The company earns $1.33 billion in net income (profit) each year or $1.87 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

Fresenius Medical Care AG & Co. KGaA employs 125,364 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?

The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.

When was Fresenius Medical Care AG & Co. KGaA founded?

Fresenius Medical Care AG & Co. KGaA was founded in 1912.

What is Fresenius Medical Care AG & Co. KGaA's official website?

The official website for Fresenius Medical Care AG & Co. KGaA is www.freseniusmedicalcare.com.

Where are Fresenius Medical Care AG & Co. KGaA's headquarters?

Fresenius Medical Care AG & Co. KGaA is headquartered at ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at (496) 172-6090, via email at [email protected], or via fax at 49-6172-609-2301.


This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.